Alexander A. Van Der Wiel
Maastricht, LI 6221ER, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Deficiencies in the Fanconi anemia or homologous recombination pathway enhance the antitumor effects of the hypoxia-activated prodrug CP-506.
Journal: Molecular therapy. Oncology
Published: September 17, 2025
Predicting homologous recombination deficiency and treatment responses using a computed tomography-based foundation model: a preclinical study.
Journal: NPJ precision oncology
Published: August 14, 2025
The Effect of Dietary Fiber Compositions on the Therapeutic Outcome of Combined Radio- and Immunotherapy in a Preclinical Cancer Model.
Journal: Molecular nutrition & food research
Published: January 20, 2025
Less is more? One-stage versus two-stage implant-based breast reconstruction: A systematic review and meta-analysis of comparative studies.
Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS
Published: May 22, 2023
Homologous Recombination Deficiency Scar: Mutations and Beyond-Implications for Precision Oncology.
Journal: Cancers
Published: July 05, 2022
Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506.
Journal: Molecular cancer therapeutics
Published: May 05, 2021
Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy.
Journal: Seminars in radiation oncology
Published: May 09, 2020
Radiomics: from qualitative to quantitative imaging.
Journal: The British journal of radiology
Published: February 27, 2020
Human fibronectin extra domain B as a biomarker for targeted therapy in cancer.
Journal: Molecular oncology
Published: February 17, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026